The role of thrombofilia related to factor V Leiden and Factor II G20210A mutations in recurrent abortions

Journal of the Pakistan Medical Association

Volumn 55, Issue 3, 2005, Pages 104-108

  Aksoy, Muge ^a   Tek, Ibrahim ^a   Karabulut, Halil ^a   Berker, Bulent ^a   Soylemez, Feride ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; EDETIC ACID; PROTHROMBIN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RECURRENT ABORTION; THROMBOPHILIA; VENOUS BLOOD;

ABORTION, HABITUAL; ADULT; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FACTOR V; FEMALE; GENOTYPE; HUMANS; PAKISTAN; PHENOTYPE; PLACENTAL CIRCULATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY, HIGH-RISK; PREVALENCE; PROTHROMBIN; RISK FACTORS; THROMBOPHILIA;

EID: 17644367892     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Preston FE, Rosendaal FR, Walker ID, Brief E, Berntorp E, Cozard J, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913-16.
2. Spina V, Aleandri V, Merni F. The impact of the Factor V Leiden mutation on pregnancy. Hum Reprod Update 2000;6:301-6.
3. Brenner B, Mandel H, Lanir N, Younis J, Rothbart H, Ohel G, et al. Activated protein C resistance can be associated with recurrent fetal loss. Br J Haematol 1997;97:551-4.
4. Dizon-Townson DS, Kinney S, Branch DW, Word K. The factor V Leiden mutationis not a common cause of recurrent miscarriage. J Reprod Immunol 1997;34:217-23.
5. Foka ZJ, Lambropoulos AF, Saravelos H, Karas GB, Karavida A, Agorastos T. Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T are associated with recurrent miscarriages. Hum Reprod 2000;15:458-62.
6. Arias F, Romero R, Joist H, Kraus FT. Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta. J Matern Fetal Med 1998;7:277-86.
7. Grandone E, Margaglione M, Colaizzo D, Pavone G, Paladini D, Martinelli P, et al. Lower birth-weight in neonates of mothers carrying factor V 1691G-A and factor II A(20210) mutations. Haematologica 2002;87:177-81.
8. Franco RF, Trip MD, Ten Cate H, Van Den Ende A, Prins MH, Kastelein JJ. The 20210G: a mutation in the 3' untranslated region of the prothrombin gene and the risk for arterial thrombotic disease. B J Haematol 1999;104:50-4.
9. Sayli BS. Hardy-Weinberg Yasasi. Medikal Genetik 2: Temel Medikal Genetik AÜTF Yayinlari Bölüm 1982;14:421-30.
10. Brigden ML. The hypercoagulable state who how and when to test and treat. Postgrad Medicine 1997;101:249-52, 254-6, 259-62 passim
11. Blumenfeld Z, Brenner B Thrombophilia-associated pregnancy wastage. Fertil Steril 1999;72:765-74.
12. Akar N, Akar E, Dalgin G, Sozuoz A, Omurlu K, Cin S. Frequency of Factor V Leiden 1691G-A mutation in Turkish population. Thromb Haemost 1997;78:1527-28.
13. Gurgey A, Mesci L. The prevalence of Factor V Leiden (1691 G-A) mutation in Turkey. The Turkish J Pediat 1997;39:313-15.
14. Wramsby ML, Sten-Linder M, Bremme K. Primary habitual abortions are associated with high frequency of factor V Leiden mutation. Fertil Steril 2000;74:987-91.